GSI-136

DB12819InvestigationalSmall molecule

GSI-136 has been used in trials studying the treatment of Alzheimer Disease.

Chemical structure of GSI-136
Formula / weight
C11H18ClNO3S2 · 311.84 g/mol (avg)
Code names
GSI-136

Resolves to

Compound
UNII51JV4753ADCAS443989-01-3ChEMBLCHEMBL480558PubChem11358855
Structure
InChIKeyPYZFRRVBPNGCBX-SECBINFHSA-NSMILESCCC(CC)[C@@H](CO)NS(=O)(=O)C1=CC=C(Cl)S1
Targets
P49768PSEN1Q92542NCSTNQ9NZ42PSENENQ8WW43APH1BQ96BI3APH1A

What you can answer from here — as of April 02, 2025

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with GSI-136, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In